Targeted Disruption of Peptide TransporterPept1Gene in Mice Significantly Reduces Dipeptide Absorption in Intestine
Authors:
- 6 November 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 5 (6) , 1122-1130
Abstract
PEPT1 is a high-capacity, low-affinity peptide transporter that mediates the uptake of di- and tripeptides in the intestine and kidney. PEPT1 also has significance in its ability to transport therapeutic agents and because of its potential as a target for anti-inflammatory therapies. To further understand the relevance of specific peptide transporters in intestinal physiology, pharmacology and pathophysiology, we have generated Pept1 null mice by targeted gene disruption. The Pept1 gene was disrupted by insertion of a lacZ reporter gene under the control of the endogenous Pept1 promoter. Phenotypic profiling of wild-type and Pept1 null mice was then performed, along with in vitro intestinal uptake, in situ intestinal perfusion and in vivo pharmacokinetic studies of glycylsarcosine (GlySar). Pept1 null mice lacked expression of PEPT1 protein in the intestine and kidney, tissues in which this peptide transporter is normally expressed. Pept1-deficient mice were found to be viable, fertile, grew to normal size and weight, and were without any obvious abnormalities. Nevertheless, Pept1 deletion dramatically reduced the intestinal uptake and effective permeability of the model dipeptide GlySar (i.e., by at least 80%), and its oral absorption following gastric gavage (i.e., by about 50%). In contrast, the plasma profiles of GlySar were almost superimposable between wild-type and Pept1 null animals after intravenous dosing. These novel findings provide strong evidence that PEPT1 has a major role in the in vivo oral absorption of dipeptides.Keywords
This publication has 32 references indexed in Scilit:
- Pharmaceutical and pharmacological importance of peptide transportersJournal of Pharmacy and Pharmacology, 2008
- PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal InflammationGastroenterology, 2008
- Peptide transporter 2 (PEPT2) expression in brain protects against 5‐aminolevulinic acid neurotoxicityJournal of Neurochemistry, 2007
- The oligopeptide transporter hPepT1: gateway to the innate immune responseLaboratory Investigation, 2006
- Functional expression of the peptide transporter PEPT2 in the mammalian enteric nervous systemJournal of Comparative Neurology, 2005
- Deletion of the Intestinal Peptide Transporter Affects Insulin and TOR Signaling in Caenorhabditis elegansJournal of Biological Chemistry, 2004
- Molecular and Integrative Physiology of Intestinal Peptide TransportAnnual Review of Physiology, 2004
- Substrate upregulation of the human small intestinal peptide transporter, hPepT1The Journal of Physiology, 1998
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsCell, 1994
- Expression cloning of a mammalian proton-coupled oligopeptide transporterNature, 1994